Breaking News Instant updates and real-time market news.

ESPR

Esperion

$43.92

-0.7 (-1.57%)

08:25
07/10/18
07/10
08:25
07/10/18
08:25

Esperion to host analyst and investor day

Analyst and Investor Day to be held in New York on July 10 at 9 am. Webcast Link

  • 10

    Jul

  • 11

    Jul

ESPR Esperion
$43.92

-0.7 (-1.57%)

05/03/18
COWN
05/03/18
NO CHANGE
Target $95
COWN
Outperform
Concerns about safety of Esperion's bempedoic acid overdone, says Cowen
After speaking with Esperion management and a key opinion leader consultant, Cowen analyst Chris Shibutani said he believes that investor concerns regarding the safety profile of Esperion's bempedoic acid, in particular stemming from the numerical difference reported in CV-related deaths in the "Study 1" readout, are overdone. The analyst, who sees the pullback presenting a buying opportunity, keeps an Outperform rating and $95 price target on Esperion shares.
05/04/18
JEFF
05/04/18
NO CHANGE
Target $85
JEFF
Buy
Esperion share recovery could happen, says Jefferies
After hosting investor meetings with management, Jefferies analyst Michael Yee concluded that despite the "visceral market reaction," investors who "understand the details" come away with a consensus view that bempedoic acid is not causing cancer and not causing cardiovascular deaths. This is positive and a "stock repair" could happen if the company lays out the details of the deaths clearly and the three studies coming in May, August and September support a positive safety picture, Yee tells investors in a research note. He has a Buy rating on Esperion with an $85 price target.
05/16/18
UBSW
05/16/18
NO CHANGE
Target $75
UBSW
Buy
Esperion price target lowered to $75 from $90 at UBS
UBS analyst Carter Gould lowered his price target on Esperion to $75 from $90 to reflect the likely overhang of approval concerns for bempedoic acid following Study 1 data. The analyst believes bempedoic acid will ultimately be approved, but noted concerns about the imbalance of elevated liver enzymes and the magnitude of LDL reduction. Gould maintained his Buy rating on Esperion shares.
05/23/18
JMPS
05/23/18
NO CHANGE
Target $153
JMPS
Outperform
Esperion Study 3 results look 'solid,' safety data 'clean,' says JMP Securities
JMP Securities analyst Jason Butler said the results of the third of Esperion's four Phase 3 trials evaluating bempedoic acid for the treatment of elevated LDL-C looked "solid" and "clearly clinically significant." The safety profile was "clean" and consistent with prior trials, added Butler, who maintains an Outperform rating and $153 price target on Esperion shares.

TODAY'S FREE FLY STORIES

TLT

iShares 20+ Year Treasury Bond Fund

$120.78

-1.46 (-1.19%)

07:49
07/23/18
07/23
07:49
07/23/18
07:49
Technical Analysis
iShares 20+ Year Treasury Bond Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLV

iShares Silver Trust

$14.59

0.18 (1.25%)

07:49
07/23/18
07/23
07:49
07/23/18
07:49
Technical Analysis
iShares Silver Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTSV

Forty Seven

$15.80

0.1 (0.64%)

07:48
07/23/18
07/23
07:48
07/23/18
07:48
Initiation
Forty Seven initiated  »

Forty Seven initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USLV

VelocityShares 3x Long Silver ETN

$8.04

0.305 (3.95%)

07:48
07/23/18
07/23
07:48
07/23/18
07:48
Technical Analysis
VelocityShares 3x Long Silver ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARPO

Aerpio Pharmaceuticals

$4.16

0.07 (1.71%)

07:48
07/23/18
07/23
07:48
07/23/18
07:48
Initiation
Aerpio Pharmaceuticals initiated  »

Aerpio Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTSV

Forty Seven

$15.80

0.1 (0.64%)

07:48
07/23/18
07/23
07:48
07/23/18
07:48
Initiation
Forty Seven initiated  »

Forty Seven initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYR

DJ US Real Estate Index Fund

$80.23

-0.68 (-0.84%)

07:48
07/23/18
07/23
07:48
07/23/18
07:48
Technical Analysis
DJ US Real Estate Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVT

nVent Electric

$24.60

-0.745 (-2.94%)

07:48
07/23/18
07/23
07:48
07/23/18
07:48
Hot Stocks
nVent Electric announces three-year share repurchase autorization of $500M »

The nVent board approved…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

IBB

iShares Nasdaq Biotechnology Index

$118.23

-0.14 (-0.12%)

07:47
07/23/18
07/23
07:47
07/23/18
07:47
Technical Analysis
iShares Nasdaq Biotechnology Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LABD

Daily S&P Biotech Bear 3x Shares

$22.08

0.1 (0.45%)

07:47
07/23/18
07/23
07:47
07/23/18
07:47
Technical Analysis
Daily S&P Biotech Bear 3x Shares: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTGN

Neon Therapeutics

$11.11

0.11 (1.00%)

07:46
07/23/18
07/23
07:46
07/23/18
07:46
Initiation
Neon Therapeutics initiated  »

Neon Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUVA

NuVasive

$53.64

-0.35 (-0.65%)

07:46
07/23/18
07/23
07:46
07/23/18
07:46
Conference/Events
NuVasive management to meet with BTIG »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 31

    Jul

  • 14

    Aug

  • 15

    Aug

  • 21

    Aug

  • 27

    Aug

CPTA

Capitala Finance

$8.65

0.0183 (0.21%)

07:46
07/23/18
07/23
07:46
07/23/18
07:46
Hot Stocks
Capitala Group leads $27.3M investment in Optio RX »

Capitala Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

NTGN

Neon Therapeutics

07:46
07/23/18
07/23
07:46
07/23/18
07:46
Initiation
Neon Therapeutics initiated  »

Neon Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWH

MSCI Hong Kong Index

$24.40

0.245 (1.01%)

07:46
07/23/18
07/23
07:46
07/23/18
07:46
Recommendations
MSCI Hong Kong Index analyst commentary  »

MSCI Hong Kong Index:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWG

iShares MSCI Germany

$30.77

-0.075 (-0.24%)

07:46
07/23/18
07/23
07:46
07/23/18
07:46
Technical Analysis
iShares MSCI Germany: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCAU

Fiat Chrysler

$19.33

-0.195 (-1.00%)

07:45
07/23/18
07/23
07:45
07/23/18
07:45
Periodicals
Fiat Chrysler's Europe chief Alfredo Altavilla resigns, Bloomberg reports »

Alfredo Altavilla, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IJR

iShares Core S&P Small Cap ETF

$86.72

-0.31 (-0.36%)

07:44
07/23/18
07/23
07:44
07/23/18
07:44
Technical Analysis
iShares Core S&P Small Cap ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EEM

MSCI Emerging Markets Index

$43.97

0.64 (1.48%)

07:44
07/23/18
07/23
07:44
07/23/18
07:44
Technical Analysis
MSCI Emerging Markets Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BWA

BorgWarner

$44.37

-0.66 (-1.47%)

07:44
07/23/18
07/23
07:44
07/23/18
07:44
Recommendations
BorgWarner analyst commentary  »

BorgWarner price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 18

    Sep

MPWR

Monolithic Power

$140.71

-1.05 (-0.74%)

07:44
07/23/18
07/23
07:44
07/23/18
07:44
Conference/Events
Monolithic Power management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 26

    Jul

  • 30

    Jul

  • 14

    Aug

LITE

Lumentum

$54.35

-5.05 (-8.50%)

, AAPL

Apple

$191.29

-0.66 (-0.34%)

07:43
07/23/18
07/23
07:43
07/23/18
07:43
Recommendations
Lumentum, Apple analyst commentary  »

Lumentum price target…

LITE

Lumentum

$54.35

-5.05 (-8.50%)

AAPL

Apple

$191.29

-0.66 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

EWW

iShares MSCI Mexico

$50.47

0.37 (0.74%)

07:43
07/23/18
07/23
07:43
07/23/18
07:43
Technical Analysis
iShares MSCI Mexico: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRX

Amneal Pharmaceuticals

$18.52

0.03 (0.16%)

07:43
07/23/18
07/23
07:43
07/23/18
07:43
Initiation
Amneal Pharmaceuticals initiated  »

Amneal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

LAZ

Lazard

$50.83

-0.09 (-0.18%)

07:43
07/23/18
07/23
07:43
07/23/18
07:43
Conference/Events
Lazard management to meet with Sandler O'Neill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 30

    Jul

  • 31

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.